{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:19:03Z","timestamp":1781540343473,"version":"3.54.5"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T00:00:00Z","timestamp":1271980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Research on Intractable Diseases"},{"name":"Ministry of Health, Labor and Welfare"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bortezomib enhances T cell apoptosis by inhibiting NF-\u03baB activation, thereby suppressing cutaneous T cell-dependent inflammatory responses by reducing interferon-\u03b3 production.<\/jats:p>\n               <jats:p>CHS is a cutaneous, T cell-dependent, inflammatory reaction mediated mainly by antigen-specific effector T cells. Bortezomib is a proteasome inhibitor that has shown impressive efficacy for the treatment of multiple myeloma. In the current study, we have assessed the effect of bortezomib treatment of CHS in mice and found that bortezomib potently inhibited CHS responses. The attenuation of CHS responses was associated with decreased inflammatory cell infiltration in the challenged skin. Specifically, bortezomib-treated mice showed significantly decreased numbers of CD4+ and CD8+ T cells in the challenged skin and draining lymph nodes. Cytoplasmic IFN-\u03b3 production by CD4+ and CD8+ T cells in the draining lymph nodes was decreased substantially by bortezomib treatment. Notably, bortezomib enhanced T cell apoptosis by inhibiting NF-\u03baB activation during CHS responses. Thus, bortezomib treatment is likely to induce T cell death, thereby suppressing CHS responses by reducing IFN-\u03b3 production. These findings suggest that bortezomib treatment could be a promising strategy for treating autoimmune and inflammatory disease.<\/jats:p>","DOI":"10.1189\/jlb.1009666","type":"journal-article","created":{"date-parts":[[2010,4,24]],"date-time":"2010-04-24T02:10:56Z","timestamp":1272075056000},"page":"117-122","source":"Crossref","is-referenced-by-count":29,"title":["The proteasome inhibitor bortezomib inhibits T cell-dependent inflammatory responses"],"prefix":"10.1093","volume":"88","author":[{"given":"Koichi","family":"Yanaba","sequence":"first","affiliation":[{"name":"Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Yoshizaki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Muroi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihide","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences , Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, University of Tokyo , Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,4,23]]},"reference":[{"key":"2023033005105899100_cit1","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.145.9.2833","article-title":"Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization","volume":"145","author":"Kripke","year":"1990","journal-title":"J. Immunol."},{"key":"2023033005105899100_cit2","doi-asserted-by":"crossref","first-page":"6783","DOI":"10.4049\/jimmunol.165.12.6783","article-title":"CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity","volume":"165","author":"Wang","year":"2000","journal-title":"J. Immunol."},{"key":"2023033005105899100_cit3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1126\/science.274.5293.1652","article-title":"How proteolysis drives the cell cycle","volume":"274","author":"King","year":"1996","journal-title":"Science"},{"key":"2023033005105899100_cit4","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1073\/pnas.95.6.2727","article-title":"The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death","volume":"95","author":"Ciechanover","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033005105899100_cit5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80929-0","article-title":"The proteasome: paradigm of a self-compartmentalizing protease","volume":"92","author":"Baumeister","year":"1998","journal-title":"Cell"},{"key":"2023033005105899100_cit6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrc1361","article-title":"The proteasome: a suitable antineoplastic target","volume":"4","author":"Adams","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"2023033005105899100_cit7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/107327480301000502","article-title":"Bortezomib (PS-341): a novel, first-in-class proteasome inhibitor for the treatment of multiple myeloma and other cancers","volume":"10","author":"Richardson","year":"2003","journal-title":"Cancer Control"},{"key":"2023033005105899100_cit8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1763","article-title":"The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis","volume":"14","author":"Neubert","year":"2008","journal-title":"Nat. Med."},{"key":"2023033005105899100_cit9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00007890-200107270-00005","article-title":"A proteasome inhibitor effectively prevents mouse heart allograft rejection","volume":"72","author":"Luo","year":"2001","journal-title":"Transplantation"},{"key":"2023033005105899100_cit10","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1073\/pnas.0401563101","article-title":"Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib","volume":"101","author":"Sun","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033005105899100_cit11","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1182\/blood-2005-05-2118","article-title":"Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines","volume":"107","author":"Blanco","year":"2006","journal-title":"Blood"},{"key":"2023033005105899100_cit12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbrc.2003.08.141","article-title":"Cell cycle- and activation-dependent regulation of cyclosporin A-induced T cell apoptosis","volume":"310","author":"Naujokat","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2023033005105899100_cit13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"2023033005105899100_cit14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1083\/jcb.79.2.356","article-title":"Stratification, specialization, and proliferation of primary keratinocyte cultures. Evidence of a functioning in vitro epidermal cell system","volume":"79","author":"Marcelo","year":"1978","journal-title":"J. Cell Biol."},{"key":"2023033005105899100_cit15","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.4049\/jimmunol.143.12.3867","article-title":"Production of hapten-specific T cell hybridomas and their use to study the effect of ultraviolet B irradiation on the development of contact hypersensitivity","volume":"143","author":"Bigby","year":"1989","journal-title":"J. Immunol."},{"key":"2023033005105899100_cit16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1525-1578(10)60652-6","article-title":"A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR","volume":"3","author":"Meijerink","year":"2001","journal-title":"J. Mol. Diagn."},{"key":"2023033005105899100_cit17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0076-6879(01)33046-X","article-title":"Ras regulation of NF-\u03baB and apoptosis","volume":"333","author":"Mayo","year":"2001","journal-title":"Methods Enzymol."},{"key":"2023033005105899100_cit18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2567.2007.02761.x","article-title":"Proteasome inhibition suppresses essential immune functions of human CD4+ T cells","volume":"124","author":"Berges","year":"2008","journal-title":"Immunology"},{"key":"2023033005105899100_cit19","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/eji.200838413","article-title":"Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation","volume":"38","author":"Fissolo","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"2023033005105899100_cit20","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/jid.2008.5","article-title":"Cutaneous hypersensitivities to hapten are controlled by IFN-\u03b3-upregulated keratinocyte Th1 chemokines and IFN-\u03b3-downregulated Langerhans cell Th2 chemokines","volume":"128","author":"Mori","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"2023033005105899100_cit21","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.4049\/jimmunol.168.6.3079","article-title":"Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis","volume":"168","author":"Akiba","year":"2002","journal-title":"J. Immunol."},{"key":"2023033005105899100_cit22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.189.5.779","article-title":"Cytotoxicity is mandatory for CD8+ T cell-mediated contact hypersensitivity","volume":"189","author":"Kehren","year":"1999","journal-title":"J. Exp. Med."},{"key":"2023033005105899100_cit23","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","article-title":"Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells","volume":"107","author":"Obeng","year":"2006","journal-title":"Blood"},{"key":"2023033005105899100_cit24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.LAB.0000022226.23741.37","article-title":"Role and function of the 26S proteasome in proliferation and apoptosis","volume":"82","author":"Naujokat","year":"2002","journal-title":"Lab. Invest."},{"key":"2023033005105899100_cit25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/jaut.2000.0370","article-title":"Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519","volume":"14","author":"Vanderlugt","year":"2000","journal-title":"J. Autoimmun."},{"key":"2023033005105899100_cit26","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1073\/pnas.95.26.15671","article-title":"Role of the proteasome and NF-\u03baB in streptococcal cell wall-induced polyarthritis","volume":"95","author":"Palombella","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033005105899100_cit27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0091-6749(99)70369-6","article-title":"Proteasome inhibition: a novel mechanism to combat asthma","volume":"104","author":"Elliott","year":"1999","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1189%2Fjlb.1009666","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/88\/1\/117\/49657470\/jlb0117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/88\/1\/117\/49657470\/jlb0117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T19:43:04Z","timestamp":1680205384000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/88\/1\/117\/6959789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,23]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,4,23]]},"published-print":{"date-parts":[[2010,4,23]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.1009666","relation":{},"ISSN":["1938-3673","0741-5400"],"issn-type":[{"value":"1938-3673","type":"electronic"},{"value":"0741-5400","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,7]]},"published":{"date-parts":[[2010,4,23]]}}}